Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1945]
News [3584]
Articles [92]
Editorials [5]
Conferences [157]
elearning [19]
Melanoma 'deceives' the immune system, increasing resistance to immunotherapy
Melanoma 'deceives' the immune system, increasing resistance to immunotherapy
ecancermedicalscience moves to Open Journal Systems
ecancermedicalscience moves to Open Journal Systems
Oncotarget: Th1 cytokines potentiate apoptosis of breast cancer cells and suppress tumour growth
Oncotarget: Th1 cytokines potentiate apoptosis of breast cancer cells and suppress tumour growth
Immunotherapy combo halts rare, stage 4 sarcoma in teen
Immunotherapy combo halts rare, stage 4 sarcoma in teen
Neo-adjuvant immunotherapy combination effective for non-metastatic bladder cancer
Neo-adjuvant immunotherapy combination effective for non-metastatic bladder cancer
Circulating tumour DNA may predict clinical outcomes with first-line, but not second-line, immunotherapy for melanoma
Circulating tumour DNA may predict clinical outcomes with first-line, but not second-line, immunotherapy for...
Oncotarget: Exosomal lncRNA PCAT-1 promotes Kras-associated chemoresistance
Oncotarget: Exosomal lncRNA PCAT-1 promotes Kras-associated chemoresistance
A promising new tool in the fight against melanoma
A promising new tool in the fight against melanoma
Inhibition of HDAC and mTOR may improve outcomes for relapsed/refractory Hodgkin lymphoma
Inhibition of HDAC and mTOR may improve outcomes for relapsed/refractory Hodgkin lymphoma
Inhibition of HDAC and mTOR may improve outcomes for relapsed/refractory Hodgkin lymphoma
Inhibition of HDAC and mTOR may improve outcomes for relapsed/refractory Hodgkin lymphoma

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation